Up to now, there is no direct PET imaging ligand successfully targeting TDP-43, and out of the notion that multiple pathological proteins may be present in neurodegenerative disease, several groups have investigated the utility of established tau-directed PET tracers to characterize ALS (76, 77, 92–94). Here, TARDBP is linked to amyotrophic lateral sclerosis.